FACBC PET/CT for Recurrent Prostate Cancer

NCT00562315 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: FACBC
OTHER: ProstaScinct

Sponsor

David M. Schuster, MD

Collaborators

[object Object]